Azithromycin

From Citizendium
Revision as of 20:54, 2 June 2024 by Pat Palmer (talk | contribs) (rduplicate ref name)
Jump to navigation Jump to search
This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, azithromycin is a "semi-synthetic macrolide antibiotic structurally related to erythromycin. It has been used in the treatment of Mycobacterium avium intracellular infections, toxoplasmosis, and cryptosporidiosis."[1]

Development

Azithromycin was patented in 1982.[2] Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.[3] Non-authorized generic drugs manufactured by Teva, Sandoz, and Abraxis were approved in the United States of America starting in 2005.[4]

Drug toxicity

Drug toxicity includes cardiovascular death.[5]

References

  1. Anonymous (2024), Azithromycin (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. patent:4328334 - Google Patents. Retrieved on 2009-02-01.
  3. Drugs@FDA. Food and Drug Administration. Retrieved on 2009-02-01.
  4. Drugs@FDA. Food and Drug Administration. Retrieved on 2009-02-01.
  5. Ray et al. (2012) Azithromycin and the Risk of Cardiovascular Death